LEGN logo

Legend Biotech (LEGN) Cash From Operations

Annual CFO

-$144.03 M
+$249.24 M+63.38%

December 31, 2024

Summary

Performance

1-Year Change

+63.38%

3-Year Change

+27.43%

5-Year Change

-73.4%

15-Year Change

-146.81%

LEGN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.06%
LEGN annual cash flow from operations is higher than 9.06% of companies in Healthcare sector

High & Low

All-time High

$307.68 M
LEGN annual cash flow from operations is currently -146.81% below its historical high of $307.68 million

3-Year Low

-$393.28 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
LEGN previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
LEGN next annual earnings announcement has not yet been scheduled

OtherLEGNcash flowmetrics:

Annual CFI

-$850.54 M
LEGN annual cash flow from investing activities is -$850.54 million

Annual CFF

$5.70 M
LEGN annual cash flow from financing activities is $5.70 million

Annual FCF

-$158.14 M
LEGN annual free cash flow is -$158.14 million

Annual CAPEX

$14.11 M
LEGN annual capital expenditures is $14.11 million

Quarterly CFO

N/A

December 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

LEGN Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$19.95 M
LEGN quarterly cash flow from operations is currently at an all-time high

3-Year Low

-$139.22 M
LEGN quarterly cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
LEGN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 13, 2025
LEGN next earnings announcement is scheduled for May 13, 2025

OtherLEGNcash flowmetrics:

Quarterly CFI

-
LEGN quarterly cash flow from investing activities value is unknown

Quarterly CFF

-
LEGN quarterly cash flow from financing activities value is unknown

Quarterly FCF

-
LEGN quarterly free cash flow value is unknown

Quarterly CAPEX

-
LEGN quarterly capital expenditures value is unknown

TTM CFO

N/A

December 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

LEGN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$4.26 M
LEGN TTM cash flow from operations is currently at an all-time high

3-Year Low

-$393.28 M
LEGN TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
LEGN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 13, 2025
LEGN next earnings announcement is scheduled for May 13, 2025

OtherLEGNcash flowmetrics:

TTM CFI

-
LEGN TTM cash flow from investing activities value is unknown

TTM CFF

-
LEGN TTM cash flow from financing activities value is unknown

TTM FCF

-
LEGN TTM free cash flow value is unknown

TTM CAPEX

-
LEGN TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

LEGN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+63.4%--
3 y3 years+27.4%--
5 y5 years-73.4%--

LEGN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+63.4%
5 y5-year-73.4%+63.4%
alltimeall time-146.8%+63.4%

Legend Biotech Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$144.03 M(-63.4%)
-
-
Sep 2024
-
-$75.82 M(+4492.5%)
-$157.60 M(+10.5%)
Jun 2024
-
-$1.65 M(-110.6%)
-$142.63 M(-40.2%)
Mar 2024
-
$15.52 M(-116.2%)
-$238.54 M(-39.3%)
Dec 2023
-$393.28 M(+95.4%)
-$95.64 M(+57.2%)
-$393.28 M(+13.2%)
Sep 2023
-
-$60.85 M(-37.6%)
-$347.37 M(-3.1%)
Jun 2023
-
-$97.57 M(-29.9%)
-$358.64 M(+37.0%)
Mar 2023
-
-$139.22 M(+179.9%)
-$261.81 M(+30.1%)
Dec 2022
-$201.28 M(+1.4%)
-$49.74 M(-31.0%)
-$201.28 M(-9.0%)
Sep 2022
-
-$72.11 M(+9644.9%)
-$221.09 M(+14.2%)
Jun 2022
-
-$740.00 K(-99.1%)
-$193.57 M(-22.7%)
Mar 2022
-
-$78.69 M(+13.1%)
-$250.37 M(+26.2%)
DateAnnualQuarterlyTTM
Dec 2021
-$198.47 M(-11.0%)
-$69.55 M(+56.0%)
-$198.47 M(+7.4%)
Sep 2021
-
-$44.59 M(-22.5%)
-$184.87 M(-9.7%)
Jun 2021
-
-$57.54 M(+114.8%)
-$204.65 M(+0.3%)
Mar 2021
-
-$26.79 M(-52.1%)
-$204.00 M(-8.5%)
Dec 2020
-$223.00 M(+168.5%)
-$55.95 M(-13.1%)
-$223.00 M(-1.8%)
Sep 2020
-
-$64.37 M(+13.2%)
-$227.04 M(+59.1%)
Jun 2020
-
-$56.88 M(+24.2%)
-$142.72 M(+14.5%)
Mar 2020
-
-$45.80 M(-23.7%)
-$124.60 M(+50.0%)
Dec 2019
-$83.06 M(-127.0%)
-$59.99 M(-400.7%)
-$83.06 M(+259.9%)
Sep 2019
-
$19.95 M(-151.5%)
-$23.08 M(-46.4%)
Jun 2019
-
-$38.77 M(+810.2%)
-$43.02 M(+910.2%)
Mar 2019
-
-$4.26 M
-$4.26 M
Dec 2018
$307.68 M
-
-

FAQ

  • What is Legend Biotech annual cash flow from operations?
  • What is the all time high annual CFO for Legend Biotech?
  • What is Legend Biotech annual CFO year-on-year change?
  • What is the all time high quarterly CFO for Legend Biotech?
  • What is the all time high TTM CFO for Legend Biotech?

What is Legend Biotech annual cash flow from operations?

The current annual CFO of LEGN is -$144.03 M

What is the all time high annual CFO for Legend Biotech?

Legend Biotech all-time high annual cash flow from operations is $307.68 M

What is Legend Biotech annual CFO year-on-year change?

Over the past year, LEGN annual cash flow from operations has changed by +$249.24 M (+63.38%)

What is the all time high quarterly CFO for Legend Biotech?

Legend Biotech all-time high quarterly cash flow from operations is $19.95 M

What is the all time high TTM CFO for Legend Biotech?

Legend Biotech all-time high TTM cash flow from operations is -$4.26 M